Dublin based Theravance BioPharma signs deal with Janssen

08 February, 2018

The company as part of the deal is working on a new treatment for inflamatory intestinal diseases that could see it earning as much as $1 billion in payments.

for more on this story..

https://www.irishtimes.com/business/health-pharma/theravance-biopharma-ireland-agrees-potential-1bn-deal-1.3384740